ARCA biopharma Forecast and Stock Analysis
Technical ABIO stock analysis for February 15, 2019.
ARCA biopharma fell by -1.75% in the last day from $0.40 to $0.39 and has now fallen 3 days in a row. The price has fallen in 7 of the last 10 days and is down by -6.43% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -222 895 shares and in total 116 415 shares bought and sold for approximately $45 751.10.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the ABIO stock was $0.39. This is 1.75% less than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 7.33% from a day low at $0.38 to a day high of $0.41.
30 day high of the ABIO stock price was $0.45 and low was $0.35.
90 day high was $0.56 and low was $0.26.
52 week high for the ARCA biopharma - $1.75 and low - $0.26.
ARCA biopharma lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -23.80% during the next 3 months and, with 90% probability hold a price between $0.15 and $0.38 at the end of this period.
ARCA biopharma holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $0.39 and $0.39. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Wednesday February 13, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 40 and the stock is currently not being overbought or oversold
Support & Resistance
ARCA biopharma finds support from accumulated volume at $0.39.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.03 between high and low, or 7.33%. For the last week the stock has had a daily average volatility of 10.52%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
ARCA biopharma holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.